ArticleBritish journal of clinical pharmacology2012

Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.

Sebastian Härtter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.